Matthew Sharpe

Stock Analyst at Morgan Stanley

(1.92)
# 1,987
Out of 4,667 analysts
93
Total ratings
52.38%
Success rate
-0.7%
Average return

Stocks Rated by Matthew Sharpe

Planet Labs PBC
Jun 12, 2023
Maintains: Equal-Weight
Price Target: $6$5.5
Current: $3.14
Upside: +75.16%
Parsons
May 16, 2023
Maintains: Underweight
Price Target: $39$41
Current: $95.30
Upside: -56.98%
Montrose Environmental Group
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $47$43
Current: $17.94
Upside: +139.69%
Leidos Holdings
Feb 15, 2023
Maintains: Equal-Weight
Price Target: $111$105
Current: $162.15
Upside: -35.25%
CACI International
Feb 2, 2023
Maintains: Overweight
Price Target: $355$357
Current: $454.90
Upside: -21.52%
Booz Allen Hamilton Holding
Feb 2, 2023
Maintains: Overweight
Price Target: $118$116
Current: $144.19
Upside: -19.55%
Science Applications International
Jan 3, 2023
Downgrades: Equal-Weight
Price Target: $108$114
Current: $123.05
Upside: -7.35%
Primoris Services
Nov 16, 2022
Maintains: Overweight
Price Target: $30$28
Current: $80.42
Upside: -65.18%
Northrop Grumman
Jan 7, 2021
Maintains: Overweight
Price Target: $470$453
Current: $491.98
Upside: -7.92%
Lockheed Martin
Jan 7, 2021
Maintains: Overweight
Price Target: $509$480
Current: $534.73
Upside: -10.24%
Maintains: Overweight
Price Target: $248$235
Current: $244.36
Upside: -3.83%
Maintains: Underweight
Price Target: $146$151
Current: $280.05
Upside: -46.08%